Policymakers Clash Over AAAS Report on Funding Crisis

Leon Lederman wants U S to double academic science budget, but critics say his appeal is simplistic and ignores fiscal realitiess WASHINGTON -- Nobel laureate Leon Lederman's call for a doubling of federal spending on academic research was greeted with considerable skepticism last month at a meeting of science policymakers. And that's not his only problem Even some of his colleagues acknowledge that what Lederman calls a present-day crisis is, in fad, a more subtle phenomenon that won't be vis

Written byJeffrey Mervis
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The policymakers and scientists at the meeting, held at the National Academy of Sciences, were reacting to the report of a survey conducted last year by the American Association for the Advancement of Science (AAAS) at the request of Lederman, who presented the report. Lederman is president-elect of the organization, which polled science faculty at 50 research universities around the country and received about 250 responses to an open-ended questionnaire about the state of federal . funding for academic research.

Lederman said at the meeting that It the funding situation is worse now than at any time in his 40-year career. To reverse the trend, he proposes in the report that government should double its annual investment of $10 billion in basic academic research. That increase should be followed by a real growth of 9 percent each year for the rest of the decade.

Robert Bender, a professor of biology ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies